Caffeine inhibits the G2 checkpoint activated by DNA damage and enhances th
e toxicity of DNA-damaging agents towards p53-defective cancer cells. The r
elationship between structure and G2 checkpoint inhibition was determined f
or 56 caffeine analogs. Replacement of the methyl group at position 3 or 7
resulted in loss of activity, while replacement at position 1 by ethyl or p
ropyl increased activity slightly. 8-Substituted caffeines retained activit
y, but were relatively insoluble. The structure-activity profile did not re
semble those for other known pharmacological activities of caffeine. The ac
tive analogs also potentiated the killing of p53-defective cells by ionizin
g radiation, but none was as effective as caffeine.